Table 5. Mean differences of metabolic post-test values minus pre-test values. Data are mean (±SD).
|
CE (n = 8) |
Effect size |
EE (N = 8) |
Effect size |
| AUC, mmol · l-1 · h-1 |
-2.40 (2.95) * |
.81 |
-.70 (2.83) |
- |
| Fasting plasma glucose, mmol · l-1 |
-.51 (1.12) |
- |
-.19 (1.95) |
- |
| Insulin, pmol · l-1 |
2.69 (37.42) |
- |
5.95 (52.15) |
- |
| HOMA-IR |
.04 (1.81) |
- |
-.10 (2.84) |
- |
| Total cholesterol, mmol · l-1 |
.08 (.75) |
- |
-.15 (.60) |
- |
| Triglycerides, mmol · l-1 |
-.56 (.62) * |
.89 |
.05 (.62) |
- |
| HDL-C, mmol · l-1 |
.20 (.25) * |
.82 |
.11 (.33) |
- |
| LDL-C, mmol · l-1 |
.13 (.67) |
- |
-.28 (.41) |
- |
| LDL-C/HDL-C ratio |
-.30 (.52) |
- |
-.47 (.70) |
.67 |
| TC/HDL-C ratio |
-.57 (.41) * |
1.39 |
-.53 (.98) |
- |
| CK, µkat · l-1 |
.44 (1.68) |
- |
.44 (1.94) |
- |
CE: concentric exercise (uphill walking); EE: eccentric exercise (downhill walking); AUC: area under the curve of the oral glucose tolerance test; HOMA-IR: homeostasis model assessment of insulin resistance; HDL-C: high-density lipoprotein-cholesterol; LDL-C: low-density lipoprotein-cholesterol; TC: total cholesterol; CK: creatine kinase* p < 0.05 within group change (calculated with Wilcoxon test).
